Orange Health Labs Raises $30 million Series C
Orange Health Labs is a Diagnostics company tied to Diagnostics buyers are tracking this financing as a fresh capital-allocation signal.. Its latest Series C is $30M, with Mn in Series C Round. Orange Health Labs, a Bengaluru as the listed market footprint.
What it does
Orange Health Labs operates in Diagnostics.
Traction
Iron Pillar India, both existing, new investors backed the $30M Series C. Iron Pillar India backed the $30M Series C.
Trend impact
First-order signal: Iron Pillar India's backing of Orange Health Labs's $30M Series C is a specific read on orange health labs operates in diagnostics., with the article evidence pointing to iron pillar india backed the $30m series c.. Investor-economist thesis: the bull case follows operator budgets where measurable ROI and distribution quality decide whether the round compounds; it helps buyers and vendors that can turn Orange Health Labs's wedge into measurable adoption, pricing power, risk reduction, or throughput gains, while it pressures single-asset or services-heavy healthcare models that cannot show evidence quality or distribution. The bear-case reversal is execution proof: if Orange Health Labs cannot convert the new capital into repeat usage, customer expansion, margin lift, or externally verifiable outcomes, the round reads as financing momentum rather than durable market leadership. Watch clinical or provider milestones, reimbursement or regulatory progress, patient/provider adoption, follow-on capital quality.
Funding history
- June 23, 2026 · Series C · $30 million · Iron Pillar India
Products & services
- Healthcare & Life Sciences workflow monitoring tied to the funding announcement
- Customer-facing product described on the company website
- Operational tooling for healthcare & life sciences teams
- Data capture and reporting across core business processes
- Team expansion support funded by the latest round